ROUTINE ROENTGENOGRAPHY AND BONE SCAN FOLLOWING BREAST CANCER
This article was originally published in The Gray Sheet
Executive Summary
ROUTINE ROENTGENOGRAPHY AND BONE SCAN FOLLOWING BREAST CANCER treatment does not improve survival, two studies published in the May 25 Journal of the American Medical Association find. Based on the results, both studies recommend against routine follow-up of breast cancer patients with chest roentgenography and bone scan; one of the studies also recommends against routine use of liver echography and laboratory tests to detect distant metastases.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.